T 0355/23 (Fixed-dose combination against HIV/GILEAD) of 13.03.2025
- European Case Law Identifier
- ECLI:EP:BA:2025:T035523.20250313
- Date of decision
- 13 March 2025
- Case number
- T 0355/23
- Online on
- 26 May 2025
- Petition for review of
- -
- Application number
- 16798063.0
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- THERAPEUTIC COMPOSITIONS FOR TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS
- Applicant name
- Gilead Sciences, Inc.
- Opponent name
- Teva Pharmaceutical Industries Ltd.
Cooke, Richard
Sandoz GmbH - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 54(3)European Patent Convention Art 56Rules of procedure of the Boards of Appeal 2020 Art 012(4)Rules of procedure of the Boards of Appeal 2020 Art 012(6)
- Keywords
- Amendments - allowable (yes)
Novelty - (yes)
Inventive step - (yes) - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division with the order to maintain the patent based on the claims of the main request filed on 26 August 2022, and a description to be adapted thereto if necessary.